Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.sciencedirect.com/science?_ob=IssueURL&_tockey=%23TOC%235188%232003%23999789994%23376022%23FLA%23Volume_21,_Issues_5-6,_Pages_331-578_(17_January_2003)&_auth=y&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=fb17908cbe894f6d42133f78bd312483

Register or Login:   Password:     Athens Login

Vaccine
Copyright © 2003 Elsevier Science Ltd. All rights reserved Volume 21, Issues 5-6, Pages 331-578 (17 January 2003)

E-mail Articles

checked docs: display checked docs

1.	Introduction, Pages 331-332 Myron M. Levine and Timo Vesikari SummaryPlus | Full Text + Links | PDF (22 K)

---

2.	Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains, Pages 333-340 Eileen M. Barry, Zeev Altboum, Genevieve Losonsky and Myron M. Levine SummaryPlus | Full Text + Links | PDF (231 K)

---

3.

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen, Pages 341-346 David E. Katz, Arthur J. DeLorimier, Marcia K. Wolf, Eric R. Hall, Frederick J. Cassels, John E. van Hamont, Rhonda L. Newcomer, Mitra A. Davachi, David N. Taylor and Charles E. McQueen SummaryPlus | Full Text + Links | PDF (88 K)

---

4.	Prospects for a mucosally-administered vaccine against Helicobacter pylori, Pages 347-353 Ann-Mari Svennerholm SummaryPlus | Full Text + Links | PDF (88 K)

---

5.	Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa, Pages 354-360 A. D. Steele, I. Peenze, M. C. de Beer, C. T. Pager, J. Yeats, N. Potgieter, U. Ramsaroop, N. A. Page, J. O. Mitchell, A. Geyer et al. SummaryPlus | Full Text + Links | PDF (86 K)

---

6.

Rotavirus strains circulating in Africa during 1996–1999: emergence of G9 strains and P[6] strains, Pages 361-367 A. D. Steele, B. Ivanoff and African Rotavirus Network: A.D. Steele, MRC Diarrhoeal Pathogens Research Unit, MEDUNSA, Pretoria, South Africa; G. Armah, Noguchi Memorial Institute for Medical Research, Accra, Ghana; V. Akran, Institute Pasteur de Cote d'Ivoire et al. SummaryPlus | Full Text + Links | PDF (68 K)

---

7.	Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants, Pages 368-375 Kari Johansen, Ulf Schröder and Lennart Svensson SummaryPlus | Full Text + Links | PDF (126 K)

---

8.

A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus–virus like particle vaccine, Pages 376-385 Sangeeta B. Periwal, Kristin R. Kourie, Nandini Ramachandaran, Susan J. Blakeney, Sylvia DeBruin, Duzhang Zhu, Timothy J. Zamb, Larry Smith, Steve Udem, John H. Eldridge et al. SummaryPlus | Full Text + Links | PDF (160 K)

---

9.

Construction of artificial virus-like particles exposing HIV epitopes, and the study of their immunogenic properties, Pages 386-392 Larisa I. Karpenko, Leonid R. Lebedev, George M. Ignatyev, Alexander P. Agafonov, Vera A. Poryvaeva, Tatiana R. Pronyaeva, Elena I. Ryabchikova, Andrei G. Pokrovsky and Alexander A. Ilyichev SummaryPlus | Full Text + Links | PDF (238 K)

---

10.	The information network of senior citizens in Geneva, Switzerland, and progress in flu vaccination coverage between 1991 and 2000, Pages 393-398 Letizia Toscani, Laurent Gauthey and Claude-François Robert SummaryPlus | Full Text + Links | PDF (125 K)

---

11.	Immigration flows and new epidemiological evidence in southern Italy, Pages 399-400 Giovanni Gabutti, Alberto Fedele, Valerio Aprile, Marcello Guido and Pierluigi Lopalco SummaryPlus | Full Text + Links | PDF (31 K)

---

12.	Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors, Pages 401-418 Marcela F. Pasetti, Myron M. Levine and Marcelo B. Sztein SummaryPlus | Full Text + Links | PDF (226 K)

---

13.	Memory T cells and vaccines, Pages 419-430 Mark T. Esser, Rocio D. Marchese, Lisa S. Kierstead, Lynda G. Tussey, Fubao Wang, Narendra Chirmule and Michael W. Washabaugh SummaryPlus | Full Text + Links | PDF (250 K)

---

14.	The Echinococcus multilocularis 14-3-3 protein protects mice against primary but not secondary alveolar echinococcosis, Pages 431-439 M. Siles-Lucas, M. Merli, U. Mackenstedt and B. Gottstein SummaryPlus | Full Text + Links | PDF (196 K)

---

15.	Measles surveillance and control in Tunisia: 1979–2000, Pages 440-445 Olfa Bahri, Myriam Ben Halima, Mohamed Ben Ghorbal, Kaouther Dali, Zakia Arrouji, Selma Khammassi, Hinda Triki and Amine Slim SummaryPlus | Full Text + Links | PDF (262 K)

---

16.	The analysis of immune responses of a novel CC-chemokine gene from Japanese flounder Paralichthys olivaceus, Pages 446-457 Tomoya Kono, Riichi Kusuda, Eijiro Kawahara andMasahiro Sakai SummaryPlus | Full Text + Links | PDF (409 K)

---

17.

B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues: Role of adjuvants and routes of immunization, Pages 458-467 Ariane Rodríguez, Marita Troye-Blomberg, Karin Lindroth, Juraj Ivanyi, Mahavir Singh and Carmen Fernández SummaryPlus | Full Text + Links | PDF (247 K)

---

18.	When can a clinical trial be called `randomized'?, Pages 468-472 Vance W. Berger and Jeffrey D. Bears SummaryPlus | Full Text + Links | PDF (73 K)

---

19.	Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland, Pages 473-478 Wieslawa Janaszek, Nigel J. Gay and Wlodzimierz Gut SummaryPlus | Full Text + Links | PDF (287 K)

---

20.	Difficulties in measles elimination: prevalence of measles antibodies before and after mass vaccination campaign in Laos, Pages 479-484 Chushi Kuroiwa, Phoxay Xayyavong, Phengta Vongphrachanh, Bouaphan Khampapongpane, Miki Yamanaka and Satoshi Nakamura SummaryPlus | Full Text + Links | PDF (67 K)

---

21.	The binding of CpG-oligodeoxynucleotides to cell-surface and its immunostimulatory activity are modulated by extracellular acidic pH, Pages 485-490 Zhenlin Hu, Shuhan Sun and Fengjuan Zhou SummaryPlus | Full Text + Links | PDF (92 K)

---

22.	Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge, Pages 491-506 Sherritta L. Ridgely, Baoshan Zhang and Travis C. McGuire SummaryPlus | Full Text + Links | PDF (311 K)

---

23.	DNA vaccination with plasmids containing various fragments of large segment genome of infectious bursal disease virus, Pages 507-513 Hua-Chen Chang, Tsang-Long Lin and Ching-Ching Wu SummaryPlus | Full Text + Links | PDF (151 K)

---

24.

A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection, Pages 514-520 Michael Lebens, Jia-Bin Sun, Hamid Sadeghi, Malin Bäckström, Ida Olsson, Nathalie Mielcarek, Bin-Ling Li, Andre Capron, Cecil Czerkinsky and Jan Holmgren SummaryPlus | Full Text + Links | PDF (118 K)

---

25.	Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice, Pages 521-531 Joon Youb Lee, Dong-Hyeon Kim, Yeonseok Chung, Seung-Uon Shin and Chang-Yuil Kang SummaryPlus | Full Text + Links | PDF (284 K)

---

26.

Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine, Pages 532-537 Yoshihiro Shimoji, Eiji Oishi, Yoshihiro Muneta, Hideji Nosaka and Yasuyuki Mori SummaryPlus | Full Text + Links | PDF (217 K)

---

27.

Salmonella typhi and S. typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors, Pages 538-548 Shahid A. Khan, Richard Stratford, Tao Wu, Nicola Mckelvie, Trevor Bellaby, Zoe Hindle, Katharine A. Sinha, Shayne Eltze, Piero Mastroeni, Derek Pickard et al. SummaryPlus | Full Text + Links | PDF (420 K)

---

28.

Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production, Pages 549-561 Gillian Hall, Christian G. Houghton, Janne Uldal Rahbek, Jonathan R. Lamb and Elizabeth R. Jarman SummaryPlus | Full Text + Links | PDF (267 K)

---

29.	B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LTR192G in H. pylori seronegative individuals, Pages 562-565 Genevieve A. Losonsky, Karen L. Kotloff and Richard I. Walker SummaryPlus | Full Text + Links | PDF (54 K)

---

30.

Therapeutic efficacy of an E. coli strain carrying an ovalbumin allergenic peptide as a fused protein to OMPC in a murine model of allergic airway inflammation, Pages 566-578 Sara Huerta Yépez, Rogelio Hernández Pando, Leopoldo Santos Argumedo, Mario Vega Paredes, Angeles Hernández Cueto, Armando Isibasi and César R. González Bonilla SummaryPlus | Full Text + Links | PDF (616 K)

---

31.	Editorial board/Aims ans Scope, Page CO2 PDF (42 K)

---

 

E-mail Articles

Your use of this service is governed by Terms and Conditions. Please review our Privacy Policy for details on how we protect information that you supply.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.